Matthew Pauls
2013 - INSMED
In 2013, Matthew Pauls earned a total compensation of $2.4M as Chief Commercial Officer at INSMED.
Compensation breakdown
| Non-Equity Incentive Plan | $168,800 |
|---|---|
| Option Awards | $1,966,723 |
| Salary | $288,750 |
| Total | $2,424,273 |
Pauls received $2M in option awards, accounting for 81% of the total pay in 2013.
Pauls also received $168.8K in non-equity incentive plan and $288.8K in salary.
Rankings
In 2013, Matthew Pauls' compensation ranked 3,229th out of 12,286 executives tracked by ExecPay. In other words, Pauls earned more than 73.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,229 out of 12,286 | 74th |
Division Manufacturing | 1,094 out of 4,612 | 76th |
Major group Chemicals And Allied Products | 284 out of 1,466 | 81st |
Industry group Drugs | 194 out of 1,160 | 83rd |
Industry Pharmaceutical Preparations | 161 out of 890 | 82nd |
Source: SEC filing on April 17, 2014.
Pauls' colleagues
We found five more compensation records of executives who worked with Matthew Pauls at INSMED in 2013.